Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1990 1
1991 1
1996 2
1997 1
2000 1
2001 1
2003 3
2004 3
2005 2
2006 3
2007 1
2008 3
2011 3
2012 3
2013 3
2014 4
2015 1
2016 6
2017 6
2018 5
2019 8
2020 5
2021 4
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

66 results
Results by year
Filters applied: . Clear all
Page 1
Utilisation and Safety of Polyethylene Glycol 3350 With Electrolytes in Children Under 2 Years: A Retrospective Cohort.
Roy D, Akriche F, Amlani B, Shakir S. Roy D, et al. J Pediatr Gastroenterol Nutr. 2021 May 1;72(5):683-689. doi: 10.1097/MPG.0000000000003074. J Pediatr Gastroenterol Nutr. 2021. PMID: 33587408 Free PMC article.
OBJECTIVES: In the UK, Movicol paediatric plain (polyethylene glycol 3350 with electrolytes [PEG 3350+E], Norgine, UK), is licensed for chronic constipation in children 2 -11 years of age and faecal impaction (FI) from 5 years. ...Nevertheless, these d …
OBJECTIVES: In the UK, Movicol paediatric plain (polyethylene glycol 3350 with electrolytes [PEG 3350+E], Norgin …
OTC polyethylene glycol 3350 and pharmacists' role in managing constipation.
Horn JR, Mantione MM, Johanson JF. Horn JR, et al. J Am Pharm Assoc (2003). 2012 May-Jun;52(3):372-80. doi: 10.1331/JAPhA.2012.10161. J Am Pharm Assoc (2003). 2012. PMID: 22618979 Review.
OBJECTIVES: To define constipation, assess the pharmacist's role in identifying and treating constipation, and review clinical evidence for the efficacy, safety, and tolerability of polyethylene glycol (PEG) 3350 (MiraLAX-Merck Consumer Care), an osmotic laxa …
OBJECTIVES: To define constipation, assess the pharmacist's role in identifying and treating constipation, and review clinical evidence for …
Over-the-counter laxative polyethylene glycol 3350: an evidence-based appraisal.
Zurad EG, Johanson JF. Zurad EG, et al. Curr Med Res Opin. 2011 Jul;27(7):1439-52. doi: 10.1185/03007995.2011.580339. Epub 2011 May 23. Curr Med Res Opin. 2011. PMID: 21604961 Review.
RESULTS: Twenty-one studies involving a total of 1949 patients were included in the overall review of polyethylene glycol 3350. Fifteen studies used randomized designs, eight were comparative trials, seven were conducted in pediatric populations, and three ha …
RESULTS: Twenty-one studies involving a total of 1949 patients were included in the overall review of polyethylene glycol 3
Polyethylene glycol 3350 plus electrolytes for pediatric chronic constipation: An open-label clinical study in Japan.
Gondo M, Nagata S, Shinbo K, Oota A, Tomomasa T. Gondo M, et al. Pediatr Int. 2020 May;62(5):600-608. doi: 10.1111/ped.14102. Epub 2020 Apr 27. Pediatr Int. 2020. PMID: 31845426 Free PMC article. Clinical Trial.
BACKGROUND: Despite the abundance of study evidence for its efficacy and tolerability for the treatment of constipation in other countries, polyethylene glycol 3350 plus electrolytes (PEG3350+E) was not available in Japan until recently. ...Stool consistency …
BACKGROUND: Despite the abundance of study evidence for its efficacy and tolerability for the treatment of constipation in other countries, …
Using Polyethylene Glycol 3350 Plus Electrolytes in Constipated Hemodialysis Patients: A Case Series.
Endo H, Obara N, Watanabe T, Sanada S, Koike T, Masamune A. Endo H, et al. Intern Med. 2021 Feb 1;60(3):379-384. doi: 10.2169/internalmedicine.5231-20. Epub 2020 Aug 29. Intern Med. 2021. PMID: 32863362 Free PMC article.
Seven patients using stimulant laxatives participated in this study. Polyethylene glycol was administered to reduce stimulant laxatives during the six-week intervention period. The amount of stimulant laxatives decreased and spontaneous bowel movements with ideal st …
Seven patients using stimulant laxatives participated in this study. Polyethylene glycol was administered to reduce stimulant …
Safety of polyethylene glycol 3350 solution in chronic constipation: randomized, placebo-controlled trial.
McGraw T. McGraw T. Clin Exp Gastroenterol. 2016 Jul 15;9:173-80. doi: 10.2147/CEG.S111693. eCollection 2016. Clin Exp Gastroenterol. 2016. PMID: 27486340 Free PMC article.
PURPOSE: To evaluate the safety and tolerability of aqueous solution concentrate (ASC) of polyethylene glycol (PEG) 3350 in patients with functional constipation. ...No serious AEs or deaths were reported, and no patient discontinued because of an AE. …
PURPOSE: To evaluate the safety and tolerability of aqueous solution concentrate (ASC) of polyethylene glycol (PEG) 3350
Polyethylene glycol 3350 for constipation in children with dysfunctional elimination.
Erickson BA, Austin JC, Cooper CS, Boyt MA. Erickson BA, et al. J Urol. 2003 Oct;170(4 Pt 2):1518-20. doi: 10.1097/01.ju.0000083730.70185.75. J Urol. 2003. PMID: 14501649
MATERIALS AND METHODS: We review our use of polyethylene glycol 3350 in 35 girls and 11 boys with dysfunctional elimination. ...CONCLUSIONS: The efficacy, compliance and lack of significant side effects make polyethylene glycol 3350
MATERIALS AND METHODS: We review our use of polyethylene glycol 3350 in 35 girls and 11 boys with dysfunctional elimina …
Polyethylene glycol 3350 plus electrolytes for chronic constipation: a 2-week, randomized, double-blind, placebo-controlled study with a 52-week open-label extension.
Nakajima A, Shinbo K, Oota A, Kinoshita Y. Nakajima A, et al. J Gastroenterol. 2019 Sep;54(9):792-803. doi: 10.1007/s00535-019-01581-x. Epub 2019 Apr 22. J Gastroenterol. 2019. PMID: 31011797 Free PMC article. Clinical Trial.
BACKGROUND: Although polyethylene glycol 3350 plus electrolytes (PEG3350 + E) is the most widely used osmotic laxative in Europe, prospective data on its long-term (over 6 months) safety and efficacy are not available to date. ...The primary efficacy endpoint …
BACKGROUND: Although polyethylene glycol 3350 plus electrolytes (PEG3350 + E) is the most widely used osmotic laxative …
PEG 3350 Versus Lactulose for Treatment of Functional Constipation in Children: Randomized Study.
Jarzebicka D, Sieczkowska-Golub J, Kierkus J, Czubkowski P, Kowalczuk-Kryston M, Pelc M, Lebensztejn D, Korczowski B, Socha P, Oracz G. Jarzebicka D, et al. J Pediatr Gastroenterol Nutr. 2019 Mar;68(3):318-324. doi: 10.1097/MPG.0000000000002192. J Pediatr Gastroenterol Nutr. 2019. PMID: 30383579 Clinical Trial.
OBJECTIVES: The aim of this study was to compare the clinical efficacy and tolerance of polyethylene glycol 3350 (PEG) and lactulose for the treatment of functional constipation in infants and children. ...CONCLUSIONS: PEG 3350 is more effective and ca …
OBJECTIVES: The aim of this study was to compare the clinical efficacy and tolerance of polyethylene glycol 3350 (PEG) …
Prospective evaluation of 1-day polyethylene glycol-3350 bowel preparation regimen in children.
Abbas MI, Nylund CM, Bruch CJ, Nazareno LG, Rogers PL. Abbas MI, et al. J Pediatr Gastroenterol Nutr. 2013 Feb;56(2):220-4. doi: 10.1097/MPG.0b013e31826630fc. J Pediatr Gastroenterol Nutr. 2013. PMID: 22744195
OBJECTIVES: The aim of the present study was to evaluate efficacy, safety, and tolerability of a pediatric colonoscopy bowel preparation regimen composed of polyethylene glycol-3350 (PEG-3350) and a sports drink completed in a few hours. ...Basic metab …
OBJECTIVES: The aim of the present study was to evaluate efficacy, safety, and tolerability of a pediatric colonoscopy bowel preparation reg …
66 results